Arkin Capital

Arkin Bio Ventures is the biotech venture arm of Arkin Capital, a Herzliya-based investment platform with over $2 billion under management. It backs early- to later-stage biotech, life sciences, pharmaceuticals, oncology, medical device and digital health companies, including U.S. investments from Series A through later-stage rounds. The firm has acted as a co-lead investor, making it relevant for founders developing therapeutics and healthcare innovation.